Based on the Greenwich Lifesciences Inc stock forecast from 1 analysts, the average analyst target price for Greenwich Lifesciences Inc is USD 38.00 over the next 12 months. Greenwich Lifesciences Inc’s average analyst rating is Strong Buy. Stock Target Advisor’s own stock analysis of Greenwich Lifesciences Inc is Very Bearish, which is based on 0 positive signals and 5 negative signals. At the last closing, Greenwich Lifesciences Inc’s stock price was USD 9.34. Greenwich Lifesciences Inc’s stock price has changed by +0.65% over the past week, -15.93% over the past month and -26.40% over the last year.
No recent analyst target price found for Greenwich Lifesciences Inc
No recent average analyst rating found for Greenwich Lifesciences Inc
Company Overview Greenwich Lifesciences Inc
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas. Read Less
Greenwich LifeSciences, Inc., a clinical-stage biopharmaceutical company, develops novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is GP2, an immunotherapy, which is in Phase III clinical trial to prevent breast can...Read More
Frequently Asked Questions About Greenwich Lifesciences Inc (GLSI) Stock
Based on ratings from 1 analysts Greenwich Lifesciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on GLSI's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for GLSI is USD 38.00 over the next 12 months. The maximum analyst target price is USD 38 while the minimum anlayst target price is USD 38.
Unfortunately we do not have enough data on GLSI's stock to indicate if its overvalued.
The last closing price of GLSI's stock was USD 9.34.
The most recent market capitalization for GLSI is USD 0.13B.
Based on targets from 1 analysts, the average taret price for GLSI is projected at USD 38.00 over the next 12 months.
This means that GLSI's stock price may go up by +306.85% over the next 12 months.
We can't find any ETFs which contains Greenwich Lifesciences Inc's stock.
As per our most recent records Greenwich Lifesciences Inc has 3 Employees.
Greenwich Lifesciences Inc's registered address is Building 14, Stafford, TX, United States, 77477.
You can get more information about it from Greenwich Lifesciences Inc's website at https://greenwichlifesciences.com.
Heading 1
Heading 2
Heading 3
Heading 4
Heading 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Data 1
Data 2
Data 3
Data 4
Data 5
Stock Target Advisor's Analysis
This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.
What to like
There is nothing we particularly like
What not to like
Overpriced compared to book value
The stock is trading high compared to its peers median on a price to book value basis.
High volatility
The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.
Negative cashflow
The company had negative total cash flow in the most recent four quarters.
Negative free cash flow
The company had negative total free cash flow in the most recent four quarters.
Low Earnings Growth
This stock has shown below median earnings growth in the previous 5 years compared to its sector
Frequently Asked Questions About Greenwich Lifesciences Inc (GLSI) Stock
Based on ratings from 1 analysts Greenwich Lifesciences Inc's stock is Strong Buy. Stock Target Advisor's fundamental analysis is Very Bearish. The stock has 1 buy, sell and hold ratings.
Unfortunately we do not have enough data on GLSI's stock to indicate if its a good dividend stock.
Based on targets from 1 analysts, the average taret price for GLSI is USD 38.00 over the next 12 months. The maximum analyst target price is USD 38 while the minimum anlayst target price is USD 38.
Unfortunately we do not have enough data on GLSI's stock to indicate if its overvalued.
The last closing price of GLSI's stock was USD 9.34.
The most recent market capitalization for GLSI is USD 0.13B.
Based on targets from 1 analysts, the average taret price for GLSI is projected at USD 38.00 over the next 12 months.
This means that GLSI's stock price may go up by +306.85% over the next 12 months.
We can't find any ETFs which contains Greenwich Lifesciences Inc's stock.
As per our most recent records Greenwich Lifesciences Inc has 3 Employees.
Greenwich Lifesciences Inc's registered address is Building 14, Stafford, TX, United States, 77477.
You can get more information about it from Greenwich Lifesciences Inc's website at https://greenwichlifesciences.com.
Add to Watchlists
loading..
Thank you for Sharing your Stock Targets for GLSI !
Loading...
Please login to proceed
Sorry - extended search is only available for registered users.
